MS Briefs

Damage of the Lateral Geniculate Nucleus in MS

Papadopoulou, et al. Neurology. doi:10.1212/WNL.0000000000007450.


 

Key clinical point : Lateral geniculate nucleus (LGN) volume loss in multiple sclerosis (MS) indicates structural damage with potential functional relevance.

Major finding : LGN volume was reduced in patients with relapsing-remitting MS vs healthy controls and was associated with ganglion cell-inner plexiform layer (GC-IPL) thickness and correlated with optic radiation (OR) lesion volume.

Study details : A cross-sectional study of 34 patients with relapsing-remitting MS and 33 matched healthy controls.

Disclosures: The lead author received funding for speaker or travel honoraria from Sanofi-Genzyme, Bayer AG, Teva, UCB-Pharma AG, and Hoffmann-La Roche.

Citation: Papadopoulou, et al. Neurology. doi:10.1212/WNL.0000000000007450.

Recommended Reading

Risk Tolerance in MS Therapies
ICYMI Multiple Sclerosis
Increased Incidence of Myocardial Infarction in MS
ICYMI Multiple Sclerosis
Imaging mass cytometry sheds light on inflammation, demyelination in MS
ICYMI Multiple Sclerosis
FDA approves Mavenclad for treatment of relapsing MS
ICYMI Multiple Sclerosis
Cerebellar volume may predict disability in patients with relapsing-remitting MS
ICYMI Multiple Sclerosis
A blood biomarker for MS: Coming to clinics soon?
ICYMI Multiple Sclerosis
Cerebellar Volume May Predict Disability in Patients With Relapsing-Remitting MS
ICYMI Multiple Sclerosis
Which Comorbidities Diminish Quality of Life in Patients with MS?
ICYMI Multiple Sclerosis
What Happens When RRMS Patients Discontinue Their DMT?
ICYMI Multiple Sclerosis
Survey of MS Patients Reveals Pregnancy-Related Concerns
ICYMI Multiple Sclerosis